{"nct_id":"NCT05987332","title":"IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma","status":"RECRUITING","status_verified_date":"2025-03","start_date":"2023-10-31","start_date_type":"ACTUAL","primary_completion_date":"2027-01-15","primary_completion_date_type":"ESTIMATED","completion_date":"2028-01-15","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["IDYA"]}